Health News Releases

February 13, 16:00

Angelalign Technology Inc. (6699.HK) Says a Preliminary European Court Ruling on Certain Software Features Will Have Minimal Impact on Users

Angelalign Technology Inc. (6699.HK) (“Angel”) said a ruling by the Unified Patent Court of Düsseldorf, Germany that it preliminarily cease its use of certain software functions that automatically upd

February 12, 15:22

We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties

Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine diverse patients

February 11, 15:30

Kirin and Immunosens Launch Joint Development of a Self-Testing Service That Uses Urinary IgA to Visualize a Person’s Immune Status

Kirin Holdings Company, Limited (Kirin Holdings) and Immunosens Co., Ltd. (Immunosens) have begun the joint development of a unique “Self-Testing Service[1]” designed to visualize a person’s immune st

February 11, 15:13

Galderma Expands Restylane® Portfolio in Japan With Launch of OBT™ Hyaluronic Acid Injectables Restylane Defyne™ and Refyne™

Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT based hyaluronic acid injectables ever authorized in J

February 10, 17:30

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54421686&newsitemid=20260210380286&lan=en-US&ancho

February 06, 15:50

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Grou

February 06, 11:40

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat® KMT2A + MRD Assay and Software to its industry-leading oncol

February 06, 10:50

InterSystems Honored with Four 2026 Best in KLAS Awards

InterSystems, a creative data technology provider powering more than one billion health records globally, today announced it has received four Global 2026 Best in KLAS awards. The company earned a #1

February 05, 13:40

China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA®

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China. It is intended

February 02, 17:16

Aesthetic Brand Lorient Showcases K-Beauty Excellence at IMCAS World Congress 2026

Lorient, a premium aesthetic brand, announced that it has attracted global attention at the 27th IMCAS World Congress 2026 in Paris, garnering over 15,000 professionals and demonstrating its leadershi

February 02, 15:13

Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission

Galderma (SIX: GALD) today announced that the U.S. FDA has accepted the BLA resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and l

January 30, 15:34

Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity

Galderma (SIX: GALD) has unveiled findings from a global survey of peri- and post-menopausal women from nine countries exploring the impact of menopause on the skin at the International Master Course

January 30, 10:50

Organon Completes Divestiture of JADA® System to Laborie

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today the successful closing of the sale of its JADA®

January 29, 15:52

Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead

Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54404180&newsitemid=20260128993781&lan=en-US&anc

January 29, 15:24

Galderma Unveils ‘Wake Up To Restylane’, Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty

Galderma (SIX: GALD), the pure-play dermatology category leader, has launched ‘Wake Up To Restylane’, a global campaign that showcases Restylane as an everyday beauty ally. Aligned with the growing de

January 29, 10:40

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. Th

January 26, 16:11

Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced financial results for the fourth quarter and fiscal year 20

January 25, 13:30

Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES

Concept Medical Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.conceptmedical.com%2F&esheet=54401002&newsitemid=20260121338054&lan=en-US&anchor=Concept+Medical+Inc.&index=

January 25, 09:30

Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis

Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and whole transcriptome analysis

January 23, 09:07

Innovative Research Unveils Potential of Pharmaceutically Processed Mica in Cancer Treatment

A South Korean research team has discovered that pharmaceutically processed mica (PMC), a mineral traditionally used in medicine, may help suppress the growth of non-small cell lung cancer (NSCLC) cel

January 23, 08:30

SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the

January 22, 14:30

International Zinc Association Partners With Pharmanova to Save Children in Zambia

Zinc Saves Kids, a global child‑health initiative of the International Zinc Association (IZA) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.zinc.org%2F&esheet=54398808&newsite

January 22, 09:16

Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership

Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the termination of a 2014 neuromo

January 21, 15:20

Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of American Pathologists (CAP) accre

January 21, 13:50

Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health

Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization’s work on oral health. The four-year funding commitment will help exp

News by Region

News by Industry